High glucose activates pituitary proopiomelanocortin gene expression: possible role of free radical-sensitive transcription factors by Asaba, Koichi et al.
 1 
High glucose activates pituitary proopiomelanocortin gene expression: 
possible role of free radical-sensitive transcription factors 
 
Koichi Asaba1 Yasumasa Iwasaki1* Masato Asai2 Masanori Yoshida2 Takeshi Nigawara2 
Machiko Kambayashi1 Kozo Hashimoto1 
 
1Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi 
University, Nankoku 783-8505, Japan 
 2Department of Medicine, Nagoya University Graduate School of Medicine, Nagoya 
466-8550, Japan 
 
Running title: Hyperglycemia activates POMC expression 
 
*Correspondence to: Yasumasa Iwasaki, M.D., Ph.D., Department of Endocrinology, 
Metabolism, and Nephrology, Kochi Medical School, Kochi University, Nankoku 783-8505, 
Japan  
Tel: +81-88-880-2343; Fax: +81-88-880-2344 
E-mail: iwasaki@med.kochi-u.ac.jp 
 
 2 
Abstract 
 
Background  Hyperglycemia is recognized as a metabolic stress, and indeed it is known to 
stimulate hypothalamo-pituitary-adrenal (HPA) axis, a representative anti-stress system, in 
patients with diabetes mellitus or in animal models of hyperglycemia.  Thus, we tried to 
clarify the molecular mechanism of glucose-induced HPA axis activation.  
 
Methods  We studied the effect of high glucose on the transcriptional regulation of 
proopiomelanocortin (POMC) gene which encodes adrenocorticotropic hormone, a central 
mediator of HPA axis using AtT20 corticotroph cell line in vitro.   
 
Results  We found that high glucose concentration (24 mM) significantly stimulated the 
5’-promoter activity of POMC gene.  The effect was promoter-specific, and was mimicked 
by nuclear factor kappa-B (NF-κB)- or AP1-responsive promoters but not by 
cAMP-responsive element- or serum response element-containing promoters.  Furthermore, 
the stimulatory effect of high glucose on POMC gene was eliminated by NF-κB and AP1 
inhibitors, suggesting the involvement of the transcriptional factors.  The POMC 
5’-promoter has the canonical NF-κB consensus sequence, and gel shift assay showed the 
binding of NF-κB to the element.  Finally, the effect of high glucose was completely 
abolished by treatment with a radical quencher TEMPOL.  
 
Conclusions  Our data suggest that hyperglycemia activates POMC gene expression, at least 
partly, via NF-κB/AP1, and that high glucose-induced free radical generation may mediate 
the activation of these transcription factors, which in turn stimulates the transcription of 
POMC gene.  
 
Key words  hyperglycemia, diabetes mellitus, proopiomelanocortin, adrenocorticoropin, 
nuclear factor-kappaB 
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Introduction 
 
Hypothalamo-pituitary-adrenal (HPA) axis is recognized as a major anti-stress system in 
higher organisms, and pituitary adrenocorticotropin (ACTH) plays a pivotal role in such a 
way that it regulates the secretion of adrenal glucocorticoid hormone under the control of 
hypothalamic releasing hormones, paracrine factors, or systemic factors.  A variety of 
stressors is known to activate HPA axis, including mental, physical, or chemical stresses such 
as hypoxia or hypoglycemia.  
   Interestingly, it has also been shown that HPA axis is activated in diabetes mellitus.  
Indeed, plasma ACTH and cortisol levels are elevated in patients with untreated diabetes 
mellitus, suggesting that hyperglycemia is a metabolic stress [1-3].  Animal experiments 
using a diabetic rat model support the observation as well [4-6].   However, the molecular 
mechanism(s) regarding the level of glucose concentration which stimulates the activity of the 
HPA axis is not known.  Recently, Nishikawa et al. have reported that high glucose 
facilitates the generation of mitochondrial oxygen radical, which is responsible for a variety 
of cellular responses in diabetes [7].  Thus, one possible explanation is that high 
glucose-induced oxidative stress is involved in the regulation of HPA axis during 
hyperglycemia.  If that is the case, oxidative stress may be one of the stresses which directly 
activates the HPA axis.  
   To test the hypothesis, in this study, we examined the effect of elevated glucose 
concentration on the expression of proopiomelanocortin (POMC) gene which encodes ACTH 
in pituitary corticotroph cells.  Our in vitro data support the hypothesis, showing that high 
glucose potently stimulates the 5’-promoter activity of the POMC gene.  The effect was 
almost completely eliminated by antioxidant treatment, suggesting the involvement of 
reactive oxygen species (ROS).  Furthermore, the radical-sensitive transcription factor 
nuclear factor kappa-B (NF-κB) and AP1 are suggested to mediate, at least in part, the effect 
of ROS-induced activation of POMC gene transcription.  
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Experimental procedures 
 
Materials   
Pyrrolidine dithiocarbamate (PDTC), curcumin, L-glucose, and 4-hydroxy-2,2,6,6- 
tetramethylpiperidine-1-oxyl (TEMPOL) were obtained from Sigma (St. Louis, MO).  H89, 
Ro-32-0432, PD98059, SB203580, and wortmannin were from Calbiochem (San Diego, CA), 
and K252a was from Alomone Labs. (Jerusalem, Israel).  pCRE (cAMP-response 
element)-Luc, pAP1-Luc, pSRE (serum-response element)-Luc, and pNF-κB-Luc were 
purchased from Stratagene (La Jolla, CA).  
 
Transfection and cell culture   
Establishment of the AtT20PL cell line used in this study was described elsewhere [8].  
Briefly, the pituitary corticotroph cell line AtT20/D16v was transfected stably with a plasmid 
(pA3Luc) containing an ≈0.7 kb fragment of the rat POMC gene 5'-promoter (-708 to +64; +1 
indicates the transcription start site), and a transformed cell line, designated as AtT20PL, was 
used for subsequent experiments.   
   The cells were maintained in a T75 culture flask with DMEM (Invitrogen, Carlsbad, CA) 
supplemented with 10% FBS (Invitrogen) and antibiotics (50 U/ml penicillin and 50 µg/ml 
streptomycin; Invitrogen) under a 5% CO2 / 95 % atmosphere at 37 °C.  Culture medium 
was changed twice a week, and the cells were subcultured once a week.   
 
Experiments   
AtT20PL cells were plated in 24-well plates with approximately 50% confluency and cultured 
with DMEM (high glucose) supplemented with 10% FBS .  Two days after plating, the 
medium was once changed to DMEM containing 3 mM glucose supplemented with 0.5% 
FBS and insulin (10 nM).  Then the cells were cultured under different concentrations of 
glucose (3-24 mM) for the defined time interval based on the protocol of each experiment.  
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At the end of incubation, the culture medium was removed, and the cells were harvested for 
the luciferase assay, as described previously [8].  In some experiments, AtT20D16v cells 
were transfected transiently with the test plasmids using a lipofection method.  The 
experimental procedure otherwise was the same as that for AtT20PL cells.  
 
RT-PCR   
RNA was isolated from the AtT20PL cells using RNeasy kit (Qiagen, Hilden, Germany), and 
5 µg of the total RNA was used for the reverse transcription reaction with SuperScript II 
reverse transcriptase (Invitrogen).  The expression of NF-κB-related proteins (p65, p50, 
IkappaB) were then analyzed by PCR with Taq DNA polymerase (Takara Shuzo, Tokyo, 
Japan) using the primer sets as follows: sense, 5’- TCAATGGCTACACAGGACCA-3’ and 
antisense, 5’- CACTGTCACCTGGAAGCAGA-3’ for mouse p65; sense, 5’- 
CACCTAGCTGCCAAAGAAGG-3’ and antisense, 5’- AGGCTCAAAGTTCTCCACCA-3’ 
for mouse p50; sense, 5’- GCCGACGCAGATGAATGGTG-3’ and antisense, 5’- 
TGTTCATTAGACAGGCCTTGGT-3’ for mouse IκBβ.  All the primer sets were designed 
to span at least one intron to avoid the genomic DNA-derived amplification.   
 
Western blot analysis 
Cellular protein was extracted by a NE-PAR nuclear and cytoplasmic extraction kit (Pierce, 
Rockford, IL), and cytoplasmic extracts were separated onto 7.5% SDS-PAGE, followed by 
electroblotting to nitrocellulose membrane.  Then the membranes were incubated with 
primary antibodies against NF-κB-p50 and p65 (Santa Cruz Biotechnology, Santa Cruz, CA) 
for 60 min at room temperature.  After washing, the secondary antibody (horseradish 
peroxidase-coupled rabbit IgG) was added and incubation was continued at room temperature.  
Membranes were then washed as above, followed by a last wash in TBS, and immunoreactive 
proteins were detected with the ECL-Western blot system (Amersham Pharmacia Biotech, 
Buckinghamshire, UK).  
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Electromobility shift assay (EMSA) 
Nuclear extract was prepared using a NE-PAR nuclear and cytoplasmic extraction kit (Pierce).  
The extract was then incubated for 6 h with the double-stranded, 3'-end-biotinylated 
oligonucleotide probe (50 fmol) encompassing the consensus NF-κB binding sequence (sense, 
5’-CGACCGGGAAGCCCCCCCTC-3’biotin, antisense, 
5’-GAGGGGGGGTTCCCGGTCG-3’biotin), or the NF-κB binding sequence in the 
5’-promoter of POMC gene (-151 to -141), and the mixture was subjected to 4% 
nondenaturing polyacrylamide gel (160V for 4 h).  Finally, the biotinylated DNA was 
transferred to a nylon membrane using capillary transfer and cross-linked, after which the 
biotin-labeled DNA was detected with digital imaging apparatus (ATTO, Japan).  
 
Data analysis   
Samples in each group of the experiments were in triplicate or quadruplicate.  All data were 
expressed as mean ± SEM.  When the statistical analyses were performed, data were 
compared by one way analysis of variance with Fisher's multiple range test, and p values 
below 0.05 were considered significant. 
 
Results 
 
Effect of high glucose on the POMC 5’-promoter activity   
We first examined the effect of high glucose on POMC gene expression in AtT20PL cells.  
As shown in Figure 1, the rise in the concentration of glucose from 3 to 24 mM significantly 
stimulated the POMC gene transcription.  The maximal effect was obtained 6 h after the 
treatment, and more than a 2-fold increase was observed.   
 
Effects of high glucose on canonical responsive elements-mediated transcription  
To clarify which signal transduction pathway(s) is involved in the high glucose-induced effect 
observed above, we then carried out a transient transfection experiment in AtT20 cells using a 
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variety of reporter constructs containing a canonical responsive element-luciferase fusion 
gene.  Among the reporter plasmids tested, similar positive effects were observed on the 
NF-κB- and AP-1-mediated transcription (Figure 2).  In contrast, high glucose did not 
influence the CRE- or SRE-mediated transcription.  These results suggest that the high 
glucose-induced effect is not a non-specific effect but rather a promoter-specific one, and that 
both of these representative stress-sensitive transcription factors are activated by high glucose.  
 
Effect of L-glucose on the POMC 5’-promoter activity  
To further confirm the specificity of the high glucose-induced effect, we compared the effect 
of D-glucose and metabolically inactive L-glucose in AtT20PL cells.  As shown in Figure 3, 
the rise in the concentration of L-glucose from 3 to 24 mM caused only an ≈30% increase in 
the POMC gene expression, whereas D-glucose stimulated it to more than 2-fold.  These 
data indicate that the effect of D-glucose is not caused by a non-specific osmogenic effect but 
by a D-glucose-specific (probably metabolic) effect.  Nonetheless, the minimal but 
significant increase by L-glucose suggests that increased osmolality may activate some 
signaling pathway(s) possibly through an osmotic stress-mediated effect.   
 
Effects of signal transduction inhibitors on high-glucose mediated POMC gene 
transcription  
To clarify the signal transduction pathway(s) involved in the observed effect more precisely, 
we tested the effect of a variety of signal transduction inhibitors on high glucose-mediated 
increase in the POMC gene 5’-promoter activity.  As shown in Figure 4, treatment of the 
cells with H89, Ro-32-0432, K252a, PD98059, and SB203580 for protein kinase A, protein 
kinase C, calmodulin kinases, p42/44 and p38 MAP kinase inhibitors, respectively, did not 
interrupt high glucose-induced POMC gene expression.  In contrast, the NF-κB inhibitor 
PDTC and the AP1 inhibitor curcumin completely eliminated the glucose-mediated increase, 
indicating that the transcription factors play central roles in the glucose-induced effect.  In 
addition, wortmannin, a phosphatidylinositol 3 kinase (PI3K) inhibitor, significantly blunted 
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the effect of high glucose, suggesting a partial involvement of the PI3K-mediated signaling 
pathway.  
 
Expression of NF-κB transcription factors in AtT20PL cells   
Since the putative NF-κB binding sites are located in the 5’-promoter region of the POMC 
gene (Figure 5A), we analyzed the expression of trans-acting factors, p50 (Rel) and p65 
(RelA), of the NF-κB components as well as IkappaB in AtT20PL cells by.  As shown in 
Figure 5B, bands corresponding to mRNA of all the protein were strongly amplified, 
suggesting that NF-κB is indeed expressed in these cells.  The expression of p50 and p65 
proteins were also confirmed by Western blotting (Figure 5C).  
 
Effect of high glucose on DNA binding of NF-κB   
To see if high glucose enhances the DNA binding of NF-κB, EMSA analysis was carried out 
using canonical or POMC 5’-promoter-derived NF-κB binding sequences as probes.  The 
results showed that high glucose treatment (24 mM for 2 h) clearly enhanced the protein 
binding to the canonical probe (Figure 6, left).  The effect on the POMC probe was less 
obvious than that on the canonical probe, but significant increase was still obtained [852 ± 25 
and 1056 ± 36 in low and high glucose groups, respectively (arbitrary unit, n=2 in each group, 
p<0.05), estimated by a densitometric analysis].  A representative photograph is shown in 
Figure 6 (right).  
 
Effect of an antioxidant TEMPOL on high-glucose mediated POMC gene transcription   
As shown above, the transcription factors NF-κB and AP-1 were activated by high glucose 
(Figure 2) in AtT20PL cells, and they are known to be both radical-sensitive [9, 10].  
Accordingly, we finally examined whether glucose-induced overproduction of free radical is 
responsible for the activation of the POMC gene transcription.  As shown in Figure 7, 
pre-treatment of the cells with TEMPOL (2 mM), a potent free radical scavenger, completely 
abolished the positive effect of glucose.  Thus, our data strongly suggest that high 
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glucose-induced activation of the POMC gene transcription is, in most part, mediated by 
oxidative stress.  
 
Discussion 
 
In this study, we found that high glucose directly increases the expression of POMC gene 
which encodes ACTH and other stress-related peptides.  Our data also showed that the same 
treatment activates the NF-κB- and AP1-dependent transcription as well.  The effect of high 
glucose on the POMC gene was completely eliminated by NF-κB inhibitor or antioxidant, 
further suggesting the involvement of ROS and ROS-sensitive NF-κB/AP1 transcription 
factors.  Altogether, the present findings indicate that hyperglycemia-induced oxidative 
stress activates HPA axis, which may account for the reported elevation of plasma ACTH and 
cortisol in patients or animal models with uncontrolled diabetes mellitus.   
   It is well known that ACTH is a key factor for regulating HPA axis, a representative 
stress-coping system in humans and mammals.  ACTH-producing pituitary corticotroph cells 
receive a variety of stress-related signals such as hypothalamic hormones (CRH, vasopressin), 
paracrine hormones, and cytokines, and after integration of these inputs, they secrete ACTH 
which specifically stimulate adrenal glucocorticoid hormone, cortisol or corticosterone, a 
representative anti-stress hormone.  Thus, synthesis and secretion of ACTH is a key step for 
regulating HPA axis in both physiological and pathological conditions.  Indeed, expression 
of ACTH is known to be elevated in a variety of stress paradigms.  The most typical stress is 
a physiological stress (pain or trauma), but emotional or even chemical stress (hypoxia or 
hypoglycemia) are known to activate HPA axis as well.  
   In addition, it has been recognized for a long time that HPA axis is also activated in 
patients with uncontrolled diabetes mellitus.  Roy et al. reported the increase in plasma 
ACTH and plasma and urinary cortisol in diabetic patients [1-3].  In vivo experiments using 
the type 2 diabetic rat model showed similar effects [4-6], and Schwartz et al. found a 
decrease in hypothalamic CRH expression despite the increase in ACTH and cortisol, 
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suggesting the existence of unknown factor(s) stimulating the HPA axis at the pituitary level 
during high blood glucose [5].  Our in vitro findings in the present study strongly suggest 
that hyperglycemia per se is a stressor, and stimulates the synthesis of ACTH in the pituitary 
cells.  The effect seems not to be a non-specific metabolic effect but rather a 
promoter-specific event, because similar effects were observed in some (NF-κB or 
AP-1-luciferase) but not in other (CRE- or SRE-luciferase ) constructs.  Furthermore, an 
equimolar concentration of metabolically inactive L-glucose only partially mimicked the 
effect of D-glucose, indicating that the event is not caused by hyperosmolality itself.  
Interestingly, however, L-glucose also had a mild but significant stimulatory effect, possibly 
due to the hyperosmolality-induced free radical generation [11, 12] (see below).  
   It is important to clarify which signal transduction pathway(s) mediates the high 
glucose-induced upregulation of POMC gene.  Our data show that high glucose had similar 
positive effects on transcription caused by NF-κB and AP-1, both of which are known to be 
oxygen radical-sensitive transcription factors.  Recent reports indicate that high glucose 
concentration elicits enhanced mitochondrial glucose oxidation, and subsequent 
overproduction of ROS, especially oxygen radicals, is responsible for a variety of 
pathological events observed in diabetic patients [7].  Based on this paradigm, it is plausible 
to speculate that high glucose-induced ROS activates NF-κB and AP-1 [10], which in turn 
exerts a positive effect on POMC gene.  The involvement of ROS is also supported by our 
finding showing that radical quencher TEMPOL completely abolished the effect of high 
glucose.  Furthermore, curcumin and PDTC, well-known antioxidants and inhibitors of AP1 
and NF-κB, respectively, also eliminated the effect, suggesting the importance of the 
transcription factors.  The binding sites of both transcription factors are located in the 
5’-promoter region of the POMC gene.  Regarding the role of NF-κB, EMSA analysis 
showed the actual binding of the protein, whereas the effect of high glucose was minimal.  
This might partly be because basal activity of NF-κB-dependent transcription is already high 
in AtT20 cells, and the glucose mediated effect on transcriptional activity is relatively low 
(≈2-fold).  Furthermore, recent studies suggest that the transactivation capacity of NF-κB is 
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determined not only by nuclear translocation (quantitative change) but also by 
phosphorylation of p65 (RelA) (qualitative change) via a variety of signaling pathways [13], 
which is not detected by EMSA.  The role of another ROS-sensitive factor AP1 in the 
transcriptional regulation of POMC gene has been well characterized previously [14].  In 
addition, our data suggest the possible involvement of the PI3K signaling pathway in high 
glucose-mediated effect, because wortmannin, a specific inhibitor of PI3K partly eliminated 
the glucose-stimulated POMC gene expression.  
   Considering the fact that the high glucose-induced ROS overproduction is a systemic 
phenomena, it may influence glucocorticoid action as well as production in vivo.  Recent 
data clearly show that NF-κB is activated in a variety of tissues throughout the body, probably 
through the generation of high glucose-induced ROS and/or advanced glycation endproduct 
(AGE) [15, 16].  Since NF-κB antagonizes glucocorticoid receptor function [17], high 
glucose is supposed to cause decreased glucocorticoid sensitivity.  Furthermore, increased 
ROS is reported to impair glucocorticoid receptor function [18, 19].  These data altogether 
suggest that high glucose with increased ROS activates HPA axis and glucocorticoid secretion 
but simultaneously impairs the sensitivity to glucocorticoid hormone in the peripheral organ.  
This may explain why the activated HPA axis does not necessarily induce clinically overt 
Cushing’s syndrome in patients with uncontrolled diabetes.  Nevertheless, the continuous 
activation of HPA axis may contribute, to some extent, to the development of central obesity 
and/or the metabolic syndrome frequently observed in diabetic patients [20].  
   In conclusion, our data show a new paradigm suggesting strongly that extracellular high 
glucose is a stress which activates HPA axis.  More specifically, glucose-induced oxidative 
stress with resultant activation of radical-sensitive transcription factors such as NF-κB may, at 
least partly, account for the molecular mechanism underlying the hyperglycemia-induced 
activation of HPA axis observed in patients with uncontrolled diabetes mellitus. 
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Figure legends 
 
Figure 1.  Effect of high glucose on the POMC 5'-promoter activity in AtT20PL cells.  
Cells were treated with DMEM containing 3 mM (control; open bar) or 24 mM glucose 
(closed bars) for the defined time interval (h).  Each value is shown as a percentage of the 
control value.  *p<0.05 vs. control (value at time 0). 
  
Figure 2.  Effect of high glucose on the CRE-, AP1-, SRE-, NF-κB-mediated transcriptional 
activity in AtT20 cells.  Cells were transfected transiently with pCRE-, pAP1-, pSRE- and 
pNF-κB-Luc reporter plasmids.  On the next day, cells were incubated for 18 h with DMEM 
containing 3 mM glucose, and then treated with DMEM containing 3 mM (open bars) or 24 
mM (closed bars) glucose for 6 h.  Each value is shown as a percentage of the value of the 3 
mM group. *p<0.05 vs. value of 3 mM group.  
 
Figure 3.  Effects of D- or L-glucose (24 mM) on the POMC 5'-promoter activity in 
AtT20PL cells.  Cells were treated with DMEM containing 3 (open bars) or 24 mM (closed 
bars) of D-glucose (left), or 3 or 24 mM of L-glucose (right) for 6 h.  Each value is shown as 
a percentage of the value of 3 mM group.  *p<0.05 vs. value of 3 mM group. 
 
Figure 4.  Effects of a variety of protein kinase inhibitors on high glucose-mediated POMC 
5'-promoter activity in AtT20PL cells.  Cells were incubated with DMEM containing 3 mM 
glucose for 18 h, and then treated with DMEM containing 3 (open bars) or 24 mM (closed 
bars) glucose for 6 h.  One hour prior to the change in glucose concentration, cells were 
treated with vehicle (control), wortmannin (Wort; 1 µM), H89 (30 µM), Ro-32-0432 (Ro; 5 
µM), K252a (K252;1 µM), curcumin (Curc; 10 µM), PDTC (100 µM), PD98059 (PD; 20 
µM), and SB203580 (SB; 10 µM) until the end of experiment.  Each value is shown as a 
percentage of the value of the corresponding 3 mM group.  *p<0.05 vs. value of 3 mM 
group.  
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Figure 5.  A.  The nucleotide sequence of the 5’-promoter region of the rat POMC gene 
used in this study.  Defined and/or putative binding sites for representative transcription 
factors including NF-κB are underlined.  B.  RT-PCR analysis of each subunit of NF-κB 
mRNA expression in AtT20PL cells.  Bands corresponding to p50, p65 and IκBβ were 
amplified.  M represents molecular size marker (100 bp ladder).  C. Western blot analysis 
of each subunit of NF-κB protein in AtT20PL cells.  Bands corresponding to p50 and p65 of 
NF-κB components were observed.  Open triangles represent molecular size marker (48 
kDa).   
 
Figure 6.  EMSA analysis.  AtT20PL cells were incubated with DMEM containing 3 mM 
glucose for 18 h, and then treated with DMEM containing either 3 or 24 mM glucose for 2 h, 
and the nuclear extracts was applied for EMSA.  Either canonical or POMC 
5’-promoter-derived NF-κB binding sequence was used as probes.  LG, low glucose (3 
mM); HG, high glucose (24 mM).  
  
Figure 7.  Effect of radical quencher TEMPOL on high glucose-mediated POMC 
5'-promoter activity in AtT20PL cells.  Cells were incubated with DMEM containing 3 mM 
glucose for 18 h, and then treated with DMEM containing either 3 mM (open bars) or 24 mM 
(closed bars) glucose for 6 h.  One hour prior to the change in glucose concentration, cells 
were treated with vehicle (control) or TEMPOL (2 mM) until the end of experiment.  Each 
value is shown as a percentage of the value of the corresponding 3 mM group.  *p<0.05 vs. 
value of 3 mM group. 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
 
 
 
 
 
ACCCACCCAACCCTGCAGGTATAAAAGAAGAGAGAAGAGTGACAGGGACC
TCGCTTGTTGCGTTGCAGAAGCGCTGCCAGGAAGGTCACGTCCAAGGCTC
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Figure 7 
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